Biovie (BIVI) Interest Coverage Ratio (2013 - 2026)
Biovie (BIVI) posted Interest Coverage Ratio of 14.72 for Q1 2026, up 69.28% sequentially from 47.9 in Q4 2025, and up 37.8% YoY from 10.68 in Q1 2025.
Biovie (BIVI) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Biovie has reported Interest Coverage Ratio for 12 years, with the latest figure at 14.72 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 37.8% year-over-year to 14.72 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 56.28 (up 62.96% YoY) and the FY2025 annual result came in at 0.24, up 47.83% from the prior year.
- Interest Coverage Ratio advanced to 14.72 in Q1 2026 per BIVI's latest filing, from 47.9 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 5.63 in Q2 2022 and troughed at 732.91 in Q2 2025.
- A 5-year average of 62.03 and a median of 12.29 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio surged 96.79% in 2022, then plunged 6631.08% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 10.45 in 2022, then fell by 2.41% to 10.7 in 2023, then tumbled by 921.73% to 109.34 in 2024, then surged by 56.19% to 47.9 in 2025, then surged by 69.28% to 14.72 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 14.72, 47.9, and 12.38 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Biovie | 14.17 Mn | 14.17 Mn | - | -1,437.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,437.77 |
| Mar 31, 2026 | -14.72 |
| Dec 31, 2025 | -47.90 |
| Sep 30, 2025 | -12.38 |
| Jun 30, 2025 | -732.91 |
| Mar 31, 2025 | -23.66 |
| Dec 31, 2024 | -109.34 |
| Sep 30, 2024 | -16.10 |
| Jun 30, 2024 | -10.89 |
| Mar 31, 2024 | -12.29 |
| Dec 31, 2023 | -10.70 |
| Sep 30, 2023 | -10.83 |
| Jun 30, 2023 | -9.98 |
| Mar 31, 2023 | -12.52 |
| Dec 31, 2022 | -10.45 |
| Sep 30, 2022 | -8.03 |
| Jun 30, 2022 | -5.63 |
| Mar 31, 2022 | -6.26 |
| Dec 31, 2021 | -21.07 |
| Sep 30, 2021 | -250.10 |